new post
StocksRunner logo
mail
search
 
menu
 
Bio-Rad Laboratories
$278.44
+1.17%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

BIO Stock Analysis & IQ Rating | Bio-Rad Laboratories

 
 

BIO

 

Bio-Rad Laboratories

$278.44

 
+$3.23 | +1.17%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$343.12
 
 
MKT CAP
$7.48B
 
52W Low
$211.43
 
 
VOL
$366.78K
 
P/E Ratio
N/A
 
 
AVG VOL
$287.97K
 
RSI
40.73
 
 
TREND
Sideways
 
 
 

BIO Stock IQ

 
lock  Login to see Bio-Rad Laboratories (BIO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

BIO Target Price

 
 
Not Enough Information
 
 
 
 

BIO Price Performance

 
 

$299.96   (-7.17%)

$320.34   (-13.08%)

$305.85   (-8.96%)

$254.47   (+9.42%)

 
 
1year
6month
3month
1month

BIO Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

Earnings

×

Earnings

BIO Earnings Sentiment Below analyst estimate
BIO Earnings Sentiment Reported a strong earnings

Rating

×

Rating

Momentum

×

Momentum

BIO Momentum Analysis Price value has negative momentum

Activity

×

Activity

Future

×

Future

BIO Analysts Opinion

BIO Analysts opinion is negative and it remained unchanged from the past 3 months

BIO Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

46%
Consensus Rating
NA
Buy
Opinion
0%
Trend
Score
100%
Potential
Score
BIO Street Sentiment

BIO Street Sentiment is unimpressive and have negative views on the near-term outlook

BIO Risk Level

BIO has Low risk level

Risk Indicators

Low volume
BIO Risk Level
Low
LOW
HIGH

BIO Performance Sentiment

Sentiments overview associated with events and the stock performance

46%
Positive
6 out of 13
events present
46%
Negative
6 out of 13
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$256.56
Resistance Price
N/A
Current Price Range
$278.44
$256.56
N/A
Show methods +
 
 

Analyst Consensus

 

Recent Upgrades and Downgrades

 
 
100%
Consensus Rating
STRONG BUY
1
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm

Oct 31, 2025

 

Reiterate

 

Buy

 

Citigroup

 
 
 
Runners Also Watch
Close Price
Change
 

A

Agilent Technologies

121.38

+0.34%

 
 
 
BIO Latest Analysis +
 
 
FAQ About BIO Stock Insights
 

What is BIO current stock price?

What are BIO stock strengths?

What is BIO Risk Level?

What is BIO market cap and volume?

What is BIO current Stock IQ?

Should I buy BIO stock right now?

Is BIO a Strong Buy right now?

What does a 'Strong Buy' rating mean for BIO?

What does a 'Strong Sell' rating mean for BIO?

What factors influence BIO's Stock IQ?

 
 
StocksRunner

Explore our BIO Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored BIO Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our BIO Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

BIO

 

Bio-Rad Laboratories

 
Set Alerts
 
 

Current Price

 

$278.44

 
+$3.23 | +1.17%
 
 
52W High
$343.12
 
 
MKT CAP
$7.48B
 
52W Low
$211.43
 
 
VOL
$366.78K
 
P/E Ratio
N/A
 
 
AVG VOL
$287.97K
 
RSI
40.73
 
 
TREND
Sideways
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 

Runners Also Watch

 
 
 
Symbol
Close
Change
 

A

Agilent Technologies

121.38

+0.34%

 
 
 
 
 
user
 
 
 
 

BIO Price Performance

 
 

$299.96   (-7.17%)

$320.34   (-13.08%)

$305.85   (-8.96%)

$254.47   (+9.42%)

 
 
1year
6month
3month
1month
 

BIO Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

Earnings

×

Earnings

BIO Earnings Sentiment Below analyst estimate
BIO Earnings Sentiment Reported a strong earnings

Rating

×

Rating

Momentum

×

Momentum

BIO Momentum Sentiment Price value has negative momentum

Activity

×

Activity

Future

×

Future

BIO Analysts Opinion

BIO Analysts opinion is negative and it remained unchanged from the past 3 months

BIO Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

46%
Consensus Rating
NA
Buy
Opinion
0%
Trend
Score
100%
Potential
Score
BIO Street Sentiment

BIO Street Sentiment is unimpressive and have negative views on the near-term outlook

BIO Risk Level

BIO has Low risk level

Risk Indicators

Low volume
BIO Risk Level
Low
LOW
HIGH
BIO Performance Sentiment
Sentiments overview associated with events and the stock performance.
46%
Positive
6 out of 13
events present
46%
Negative
6 out of 13
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$256.56
Resistance Price
N/A
Current Price Range
$278.44
$256.56
N/A
Show methods +

Latest Analyst Actions

Overall Wall Street Rating

100%
Consensus Rating
STRONG BUY
1
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm
Oct 31, 2025
Reiterate
Buy
Citigroup
 
 
 
 

BIO Stock IQ

 
 
 
lock  Login to unlock Bio-Rad Laboratories (BIO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 

Not Enough Information

 
 
 

BIO Latest Analysis

 
 
 

Bio-Rad Laboratories Inc. (BIO) Achieves Modest Revenue Growth and Robust Free Cash Flow Growth. Bio-Rad Laboratories Inc. (NYSE:BIO) is one of the best debt-free mid-cap stocks to buy according to hedge funds. On February 12 Bio-Rad Laboratories Inc. (NYSE:BIO) delivered solid fourth-quarter and full-year results despite a challenging year marked by geopolitical uncertainty and continued pressure on academic research. The company delivered modest revenue growth and strong free cash [….]

 

Thu Feb 19, 2026

$271.90 | +0.45%
 
Activity
Earnings
Potential

Bio-Rads Q4 Earnings Miss Estimates Revenues Surpass Stock Down. BIO misses Q4 EPS estimates as margins shrank and shares slid 12% despite revenue growth and a rebound in Clinical Diagnostics sales.

 

Thu Feb 19, 2026

$271.90 | +0.45%
 
Earnings
Momentum
Potential

Oversold Conditions For Bio-Rad Laboratories (BIO). Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me

 

Fri Feb 13, 2026

$256.56 | -12.04%
 
Technical
Technical

Bio-Rad Laboratories (BIO) Shares Cross Below 200 DMA. In trading on Friday shares of Bio-Rad Laboratories Inc (Symbol: BIO) crossed below their 200 day moving average of $281.97 changing hands as low as $251.00 per share. Bio-Rad Laboratories Inc shares are currently trading off about 11.7% on the day. The chart below shows the

 

Fri Feb 13, 2026

$256.56 | -12.04%
 
Technical

Bio-Rad Laboratories Swings To Q4 Profit . (RTTNews) - Bio-Rad Laboratories Inc. (BIO) a life science and diagnostic company on Thursday reported strong financial performance for the fourth quarter and full year 2025. The company posted significant improvements in net income and earnings per share compared to the prio

 

Thu Feb 12, 2026

$292.42 | -0.43%
 
Earnings

Bio-Rad Laboratories (BIO) Q4 Earnings Miss Estimates. Bio-Rad (BIO) delivered earnings and revenue surprises of -2.34% and 0.01% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

 

Thu Feb 12, 2026

$292.42 | -0.43%
 
Earnings

Bio-Rad Laboratories Inc. Non-GAAP EPS of $2.51 misses by $0.19 revenue of $693.2M beats by $5.49M.

 

Thu Feb 12, 2026

$292.42 | -0.43%
 
Earnings
Earnings
 
 
 
 
 
StocksRunner

Discover BIO Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of BIO. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our BIO Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

BIO Stock trends

BIO Stock performance

BIO Stock analysis

BIO investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

BIO Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing BIO

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing BIO

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.